Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV Part 2: Non-neutralizing antibodies. Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012.

Vaccine

Volumn 31, Issue 29, 2013, Pages 2984-2987

  Girard, Marc P ^a   Picot, Valentina ^b   Longuet, Christophe ^b   Nabel, Gary J ^c  

^a ACADÉMIE NATIONALE DE MÉDECINE   (France)

^b Fondation Mérieux ^*  (France)

^c SANOFI   (United States)

Author keywords

Antibody dependent cellular cytotoxicity; HIV vaccines; Mucosal immunity; Transcytosis inhibitory antibodies

Indexed keywords

BROADLY NEUTRALIZING ANTIBODY; FC RECEPTOR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; NON NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; B LYMPHOCYTE ACTIVATION; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION PREVENTION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCYTOSIS; VIRUS ENTRY; VIRUS INHIBITION;

AIDS VACCINES; ANTIBODIES, NEUTRALIZING; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; B-LYMPHOCYTES; FRANCE; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION;

EID: 84879009992     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.067     Document Type: Review

References (15)

1. Girard MP, Picot V, Longuet C, Nabel GJ. Report of the Cent gardes HIV Vaccine Conference: the B-cell response to HIV, Part 1: broadly neutralizing antibodies. Fondation Merieux Conference Center, Veyrier-du-Lac, France, 5-7 November 2013. Vaccine (in press), doi:S 0264-410X (13) 00259-4.
2. Reks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chien J., Paris R., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009, 361:2209-2220.
3. Haynes B.F., Gilbert P.B., McElrath M.J., Zolla-Pasner S., Tomaras G.D., Alam S.M., et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 2012, 366:1275-1286.
4. Ferrari G., Pollara J., Kozink D., Harms T., Drinker M., Freel S., et al. A HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent ADCC activity and defines a common ADCC epitope in human HIV-1 serum. J Virol 2011, 85:7029-7036.
5. Devito C., Brolinden K., Kaul R., Svensson L., Johansen K., Kiama P., et al. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol 2000, 165:5170-5176.
6. + cell infection: an IgA gene and functional analysis. Mucosal Immunol 2009, 2:412-426.
7. Anthony R.M., Kobayashi T., Wermeling F., Ravetch J.V. Intravenous immunoglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 2011, 475:110-113.
8. Rolland M., Edlefsen P.T., Larsen B.B., Tovanabutra S., Sanders-Buell E., Hertz T., et al. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature 2012, 490:417-420.
9. Burton D.R., Hessell A.J., Keele B.F., Klasse P.J., Ketas T.A., Moldt B., et al. Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody. Proc Nat Acad Sci USA 2011, 108:11181-11186.
10. Pegu P., Vaccari M., Gordon S., Keele B.F., Doster M., Guan Y., et al. Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial. J Virol 2013, 87:1708-1719.
11. Hladik F., McElrath M.J. Setting the stage- HIV host invasion. Nat Rev Immunol 2008, 8:447-457.
12. Shukair S.A., Allen S.A., Cianci G.C., Steh D.J., Anderson M.R., Baig S.M., et al. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol 2012, 10.1038/mi.2012.87.
13. Bomsel M., Tudor D., Drillet A.S., Alfsen A., Ganor Y., Roger M.G., et al. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 2011, 34:269-280.
14. Vaccari M., Keele B.F., Bosinger S.E., Doster M.N., Ma Z.M., Pollara J., et al. Protection afforded by an HIV vaccine candidate in macaques dependent on the dose of SIVmac251 challenge exposure. J Virol 2013, 87:3538-3548.
15. Girard M., Valette L A measured pace. 8 colloque des Cent Gardes - Retrovitruses of Human AIDS and Related Animal Diseases 1994, Fondation Marcel Mérieux, Lyon, France. M. Girard, L. Valette (Eds.).